NEW YORK, June 23, 2022 /PRNewswire/ -- As per Zion Market Research study, The global medical marijuana market was worth around USD 11.25 billion in 2021 and is estimated to grow to about USD 51.36 billion by 2028, with a compound annual growth rate (CAGR) of approximately 18.4 percent over the forecast period.
Key Industry Insights & Finding of the Medical Marijuana Market Reports:
- As per the analysis shared by our research analyst, the Medical Marijuana Market is expected to grow annually at a CAGR of around 18.4 % (2022-2028).
- Through the primary research, it was established that the Medical Marijuana Market was valued approximately USD 11.25 Billion in 2021 and is projected to reach to roughly USD 51.36 Billion by 2028.
- The United States is the most important country in the cannabis business and is primarily contributing to the region's market expansion.
- Growing number of legalizations relating to the use of cannabis plants for medicinal and recreational uses in over 30 states in the United States has considerably contributed to the region's expanding income.
- The growing amount of private and governmental financing for research into the medicinal relevance of marijuana will support the market expansion.
- Europe is expected to stay in the second spot in the global market. Market growth in Europe is due to the legalization of marijuana for medical and research purposes.
Zion Market Research published the latest report titled as "Medical Marijuana Market By Type (Flowers, Concentrates, Edibles And Others), By Application (Chronic Pain, Mental Disorders, Cancer, And Others), By End User (Pharmaceutical And Research & Development Centers), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028." into their research database.
Medical Marijuana Market: Overview
Medical marijuana is a plant-based medicine produced from the genus Cannabis. Cannabis is becoming increasingly popular as a result of its growing medicinal applications. It comes from the Cannabis sativa plant, which is used to treat chronic conditions and control pain. It's used to treat a specific symptom or condition, such as chronic pain, cancer, and mental health issues. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the two main cannabinoids derived from this plant that have medicinal advantages.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/medical-marijuana-market
Our Free Sample Report Includes:
- 2022 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 187 + Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Zion Market Research methodology
Industry Dynamics:
Medical Marijuana Market: Growth Drivers
- Increased use of cannabis for a variety of medical conditions will help to drive revenue growth.
The marijuana plant was utilized for medical purposes for millennia until it became legal in the early 1900s. The plant's medicinal advantages are expected to raise product demand, resulting in increased market growth. Cannabidiol (CBD) is a nonpsychoactive chemical found in the cannabis plant. CBD is thought to have a variety of medicinal properties. Epidiolex, for example, is a CBD oil extract that is now being tested for epilepsy. Furthermore, nabiximols is a plant extract that has been licensed in Europe for the therapy of spasticity, overactive bladder, multiple sclerosis, neuropathic pain, and other illnesses. According to the latest survey, the most prevalent reasons people use medicinal marijuana are for pain relief, anxiety, depression, muscular stiffness, and a few other ailments. As a result, the expanding number of research studies to uncover additional medicinal uses, together with the increasing number of advantages connected with medical marijuana, will significantly boost the global medical marijuana market growth.
Medical Marijuana Market: Restraints
- Side effects allied with the consumption of marijuana can limit the market growth.
Despite the growing use of authorized medical marijuana to treat a variety of ailments, the negative side effects linked with marijuana consumption may limit the market growth. Hallucinations, dizziness, low blood pressure, and a few other side effects are expected to limit the major market's expansion. Another important element restricting market development is a lack of public understanding of the numerous linked advantages of marijuana.
Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/medical-marijuana-market
Global Medical Marijuana Market: Opportunities
- Increasing awareness regarding the medical importance of marijuana is likely to offer better growth opportunities for market expansion.
The increased understanding of the advantages of medicinal marijuana among medical professionals, healthcare sector experts, and patients has spurred regulatory bodies to consider and allow medical marijuana. Over 30 countries, including the United States, Canada, Argentina, the United Kingdom, Australia, Germany, and many other European countries, have approved its medicinal use through various national efforts. It's also been licensed for medical use in a number of places around the United States. Medical marijuana has been the topic of intense research and debate for decades. The US Food and Drug Administration has authorized many drugs including marijuana-based formulations in healthcare because of their demonstrated medicinal advantages.
Global Medical Marijuana Market: Challenges
- A limited number of suppliers and distributors around the emerging market pose a major challenge to the market expansion.
Medical marijuana or drugs based on marijuana are largely concentrated in North America and Europe. This is due to the legalization of marijuana for medical purposes, increased awareness among the consumers, high spending power, and well-developed infrastructure for the cultivation and testing of marijuana herbs. However, the situation differs in Asia Pacific where many countries still oppose the use of marijuana and its legalization. This is directly affecting its sale in the region. Also, low awareness and high prices of these drugs make them unsuitable for a low-income population which is why distributors and suppliers in such regions are limited.
Global Medical Marijuana Market: Segmentation
- The global medical marijuana market is categorized into type, application, end-use, and region.
Based on type, the market is bifurcated into flowers, edibles, concentrates, and others. The application segment of the market is divided into chronic pain, cancer, mental disorders, and others. The end-user segment is segregated into research & development and pharmaceutical.
Get More Insight before Buying@: https://www.zionmarketresearch.com/inquiry/medical-marijuana-market
List of Key Players of Medical Marijuana Market :
- Cara Therapeutics Inc.
- Growblox Sciences Inc.
- CannaGrow Holdings Inc.
- International Consolidated Companies Inc.
- Cannabis Sativa Inc.
- United Cannabis Corporation
- GreenGro Technologies Inc.
- GW Pharmaceuticals plc
Key questions answered in this report:
- What are the growth rate forecast and market size for Medical Marijuana Market ?
- What are the key driving factors propelling the Medical Marijuana Market forward?
- What are the most important companies in the Medical Marijuana Market Industry?
- What segments does the Medical Marijuana Market cover?
- How can I receive a free copy of the Medical Marijuana Market sample report and company profiles?
Report Scope:
Report Attribute | Details |
Market size value in 2021 | USD 11.25 Billion |
Revenue forecast in 2028 | USD 51.36 Billion |
Growth Rate | CAGR of almost 18.4 % 2022-2028 |
Base Year | 2020 |
Historic Years | 2016 - 2021 |
Forecast Years | 2022 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2022 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Companies Covered | Cara Therapeutics Inc., Growblox Sciences, Inc., CannaGrow Holdings, Inc., International Consolidated Companies, Inc., Cannabis Sativa, Inc., United Cannabis Corporation, GreenGro Technologies, Inc., GW Pharmaceuticals plc, and Lexaria Corp. |
Report Coverage | Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. https://www.zionmarketresearch.com/custom/3424 |
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/medical-marijuana-market
Recent Developments
- April 2020, the Medicinal Cannabis Agency of New Zealand, which is part of the Ministry of Health, has created a new Medical Cannabis Scheme to promote patient access to high-quality medical cannabis products. The Ministry of Health created the program to allow home, commercial production, manufacturing, and distribution of medicinal cannabis while also establishing quality and licensing standards.
Regional Dominance:
- North America is expected to lead the global market over the forecast period.
North America is expected to have the largest share of the global medical marijuana market throughout the forecast period. The United States is the most important country in the cannabis business and is primarily contributing to the region's market expansion. Furthermore, the growing number of legalizations relating to the use of cannabis plants for medicinal and recreational uses in over 30 states in the United States has considerably contributed to the region's expanding income. In addition, the existence of numerous large competitors in the region is a key element boosting the medical marijuana market's growth. Furthermore, the growing amount of private and governmental financing for research into the medicinal relevance of marijuana will support the market expansion. Europe is expected to stay in the second spot in the global market. Market growth in Europe is due to the legalization of marijuana for medical and research purposes.
Global Medical Marijuana Market is segmented as follows:
Medical Marijuana Market: By Type Outlook (2022-2028)
- Flowers
- Edibles
- Concentrates
- Others
Medical Marijuana Market: By Application Outlook (2022-2028)
- Chronic Pain
- Cancer
- Mental Disorders
- Others
Medical Marijuana Market: By End User Outlook (2022-2028)
- Research & Development
- Pharmaceutical
Medical Marijuana Market: By Region Outlook (2022-2028)
North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Press Release For Medical Marijuana Market : https://www.zionmarketresearch.com/news/global-medical-marijuana-market
Browse Other Related Research Reports from Zion Market Research
- Cannabis Cultivation Market - Global Industry Analysis: The global Cannabis Cultivation Market accrued earnings worth approximately 147.3 (USD Billion) in 2020 and is predicted to gain revenue of about 359.6 (USD Billion) by 2028, is set to record a CAGR of nearly 14.5% over the period from 2021 to 2028.
- Animal Drug Compounding Market - Global Industry Analysis: The global Animal Drug Compounding market accrued earnings worth approximately 1.21(USD Billion) in 2020 and is predicted to gain revenue of about 3.31(USD Billion) by 2028, is set to record a CAGR of nearly 6.5% over the period from 2021 to 2028.
- Artificial Intelligence (AI) In Drug Discovery Market - Global Industry Analysis: The global Artificial Intelligence (AI) In Drug Discovery Market accounted for USD 261 Million in 2020 and is expected to reach USD 3,493 Million by 2028, growing at a CAGR of 38.3% from 2021 to 2028.
Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/
Blog : https://zmrblog.com/ | https://www.marketbusinessinsights.com/
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
